本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BETTERLIFE PHARMA INC.

0.0655
+0.00213.31%
成交量:2,742.00
成交額:176.17
市值:1,036.10萬
市盈率:- -
高:0.0655
開:0.0630
低:0.0630
收:0.0634
52周最高:0.1269
52周最低:0.0476
股本:1.58億
流通股本:1.10億
量比:0.15
換手率:0.00%
股息:- -
股息率:- -
淨資產收益率:-4416.54%
總資產收益率:-357.33%
市淨率:-1.52
市盈率(LYR):- -

資料載入中...

2025/06/02

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/05/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/06/07

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2023/06/01

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/06/06

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/06/05

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/06/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/06/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2019/05/21

重要事件披露

8-K - Current report
2019/05/03

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2019/02/04

重要事件披露

8-K - Current report
2018/12/19

重要事件披露

8-K - Current report
2018/12/18

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/11/06

重要事件披露

8-K - Current report
2018/09/18

重要事件披露

8-K - Current report
2018/09/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/06/19

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2018/05/16

重要事件披露

8-K/A [Amend] - Current report
2018/05/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2018/03/12

重要事件披露

8-K - Current report